Fintel reports that on March 12, 2025, Piper Sandler upgraded their outlook for Myriad Genetics (NasdaqGS:MYGN) from Neutral ...

This article explores 6-base genome sequencing and how it is empowering researchers to expand their studies to include both ...

Physician-scientist Theodore Scott Nowicki, MD, PhD, an assistant professor-in-residence of pediatric hematology/oncology and microbiology, immunology, & molecular genetics at the David Geffen School ...

In Evan's first year with the DBU men's hoops, the Patriots won the Lone Star Conference for the first time in school history ...

Hemophilia is a rare, inherited disease that causes blood to not clot as it should and can cause spontaneous bleeding. Learn how this affects your prognosis.

The market's appetite for AI applications in healthcare is rapidly increasing, with TEM emerging as a top contender in this ...

Myriad Genetics (NASDAQ:MYGN – Get Free Report) had its price objective decreased by Bank of America from $13.00 to $11.00 in ...

What if doctors could analyse your DNA to better understand your risk of developing anxiety and, more importantly, how best ...

I'd like to close by saying thank you to our Board of Directors for the opportunity to serve here at Myriad Genetics for the past 4.5 years. To my colleagues in the industry, and to everyone in ...

Sophia Genetics SA (SOPH) reports strong customer acquisition and operational efficiency, despite facing biopharma revenue declines and margin pressures.